Treatment Free Remission in CML
Full text article
References
Goldman J, Gordon M. Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?. Leukemia & lymphoma. 2006 Jan 1;47(1):1-7. doi: 10.1080/10428190500407996.
Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F, Clark RE, Cortes JE, Deininger MW, Guilhot F, Hjorth-Hansen H. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020 Apr;34(4):966-84. doi: 10.1038/s41375-020-0776-2.
Etienne G, Guilhot J, Rea D, Rigal-Huguet F, Nicolini F, Charbonnier A, Guerci-Bresler A, Legros L, Varet B, Gardembas M, Dubruille V. Long-term follow-up of the French Stop Imatinib (STIM1) study in patients with chronic myeloid leukemia. Journal of Clinical Oncology. 2017 Jan 20;35(3):298-305. doi: 10.1200/JCO.2016.68.2914.
Kadowaki N, Kawaguchi T, Kuroda J, Nakamae H, Matsumura I, Miyamoto T, Ishikawa J, Nagafuji K, Imamura Y, Yamazaki H, Shimokawa M. Discontinuation of nilotinib in patients with chronic myeloid leukemia who have maintained deep molecular responses for at least 2 years: a multicenter phase 2 stop nilotinib (Nilst) trial. Blood (ASH Annual Meeting Abstracts) 2016; 128(Suppl):790. doi: 10.1182/blood.V128.22.790.790.
Hochhaus A, Masszi T, Giles FJ, Radich JP, Ross DM, Gomez Casares MT, Hellmann A, Stentoft J, Conneally E, Garcia-Gutierrez V, Gattermann N. Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study. Leukemia. 2017 Jul;31(7):1525-31. doi: 10.1038/leu.2017.63.
Deininger MW, Shah NP, Altman JK, et al. Chronic myeloid leukaemia, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18:1385–415. doi: 10.6004/jnccn.2020.0047.
Leukaemia & Lymphoma Society, https://www.lls.org/sites/default/files/2021-05/FS34_Treatment_Free_Remission2018.
Saussele S, Richter J, Hochhaus A, Mahon FX. The concept of treatment-free remission in chronic myeloid leukemia. Leukemia. 2016 Aug;30(8):1638-47. doi: 10.1038/leu.2016.115
Authors
Copyright (c) 2024 Mohiuddin Ahmed Khan
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open access article published under the Creative Commons Attribution 4.0 International License, which permits its free use, distribution, and reproduction in any medium or format, even used for commercial purposes, provided the original work is properly cited.